Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2018 / Cilt: 52 - Sayı: 3

Does Residual Renal Function Have a Beneficial Effect on Patient and Technique Survival in Peritoneal Dialysis Patients?

Pages
182–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Peritonitis rates and technique survival were not different for patients with anuria and without anuria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Residual renal function (RRF) at the initiation of peritoneal dialysis (PD) therapy can be a predictor of survival in stable PD patients.
📊
Key Findings & Data:Methods: Urine output at the beginning of PD therapy was evaluated retrospectively in 202 PD patients.
💡
Conclusion & Impact:Peritonitis rates and technique survival were not different for patients with anuria and without anuria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Residual renal function (RRF) at the initiation of peritoneal dialysis (PD) therapy can be a predictor of survival in stable PD patients. The aim of the present study was to investigate PD patients regarding the effect of baseline RRF on patient and technique survival. Methods: Urine output at the beginning of PD therapy was evaluated retrospectively in 202 PD patients. Patients were divided into two groups: patients with anuria (urine output ≤100 ml/day) and patients without anuria (urine output >100 ml/day). Results: The number of patients with anuria was 58 in which 38 patients were females. The mean age of the patients was 42.8±14.9 years. The mean follow-up period was 44.2±35 months. Twelve percent of patients with anuria had history of hemodialysis (HD). One hundred forty-four had no anuria (68 females, mean age 43.7±14.5 years, mean follow-up period 39.6 ± 26.1 months, mean urine volume 592±442 ml). Twenty-three patients had received HD therapy before. Sixty-five had anuria in the following 22.5±19.6 months. At the beginning of therapy, systolic and diastolic blood pressures were lower in patients with oliguria than in patients without oliguria (p 0.05). The peritonitis rate was one episode per 28.2 versus 30 patient-months for the anuric and non-anuric groups, respectively (p>0.05). For Kaplan–Meier survival analysis, the mean technique survival rates at 1 and 3 years were 97% and 86.6% in patients without anuria and 94% and 85.3% in patients with anuria, respectively. The 5-year technique survival rates according to residual volume states were not statistically significant with log-rank test (p>0.05). The 1-, 3-, and 5-year survival rates were 96.9%, 89.6%, and 86.5% in patients without anuria, respectively, whereas they were 87.3%, 77.3%, and 53.7% in patients with anuria, respectively. The 5-year survival rates according to residual volume states were statistically significant (p<0.05). Conclusion: RRF at the beginning of PD has an important and positive impact on patient survival in PD patients. Peritonitis rates and technique survival were not different for patients with anuria and without anuria.

🔖

Cite This Article

AHBAP, E., SEVİNÇ, M. (2018). Does Residual Renal Function Have a Beneficial Effect on Patient and Technique Survival in Peritoneal Dialysis Patients?. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 52 - Sayı: 3, 182–187. https://ajindex.com/articles/363989

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556–64.
  2. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002;62:1046–53.
  3. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158–62.
  4. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006;69:1726–32.
  5. Jager KJ, Merkus MP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, et al; NECOSAD Study Group. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001;12:1272–9.
  6. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002;62:639–47.
  7. Mehrotra R, Khanna R, Yang TC, Kathuria P, Moore HL, Prowant BF, et al. Calculation of 6-hour D/P creatinine ratio from the 4-hour peritoneal equilibration test. The effect of dwell duration on the results. Perit Dial Int 1997;17:273–8.
  8. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:85–90.
  9. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004;15:1061–70.
  10. Hu SL, Joshi P, Kaplan M, Lefkovitz J, Poenariu A, Dworkin LD, et al. Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis Patients. Perit Dial Int 2017;37:477–81.
  11. Maitra S, Burkart J, Fine A, Prichard S, Bernardini J, Jindal KK, et al. Patients on chronic peritoneal dialysis for ten years or more in North America. Perit Dial Int 2000:S127–33. Lameire N, Van Biesen W. Hypervolemia in peritoneal dialysis patients. J Nephrol 2004;17 Suppl 8:S58–66. Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Johnson DW; balANZ trial inve